Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
- PMID: 11779868
- DOI: 10.1074/jbc.M110547200
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
Abstract
Gab1-SHP2 association is required for Erk mitogen-activated protein kinase activation by several growth factors. Gab1-SHP2 interaction activates SHP2. However, an activated SHP2 still needs to associate with Gab1 to mediate Erk activation. It was unclear whether SHP2 is required to dephosphorylate a negative phosphorylation site on Gab1 or whether SHP2 needs the Gab1 pleckstrin homology (PH) domain to target it to the plasma membrane. We found that expression of a fusion protein consisting of the Gab1 PH domain and an active SHP2 (Gab1PH-SHP2DeltaN) induced constitutive Mek1 and Erk2 activation. Linking the active SHP2DeltaN to the PDK1 PH domain or the FRS2beta myristoylation sequence also induced Mek1 activation. Mek1 activation by Gab1PH-SHP2DeltaN was inhibited by an Src inhibitor and by Csk. Significantly, Gab1PH-SHP2DeltaN induced Src activation. Gab1PH-SHP2DeltaN expression activated Ras, and the Gab1PH-SHP2DeltaN-induced Mek1 activation was blocked by RasN17. These findings suggest that Gab1PH-SHP2DeltaN activated a signaling step upstream of Src and Ras. The SHP2 tyrosine phosphatase activity is essential for the function of the fusion protein. Together, these data show that the Gab1 sequence, besides the PH domain and SHP2 binding sites, is dispensable for Erk activation, suggesting that the primary role of Gab1 association with an activated SHP2 is to target it to the membrane.
Similar articles
-
Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.J Biol Chem. 2001 Jun 29;276(26):24380-7. doi: 10.1074/jbc.M010275200. Epub 2001 Apr 25. J Biol Chem. 2001. PMID: 11323411
-
Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor.J Biol Chem. 2000 May 5;275(18):13842-8. doi: 10.1074/jbc.275.18.13842. J Biol Chem. 2000. PMID: 10788507
-
Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.Hum Mutat. 2004 Mar;23(3):267-77. doi: 10.1002/humu.20005. Hum Mutat. 2004. PMID: 14974085
-
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.Cell Signal. 2008 Mar;20(3):453-9. doi: 10.1016/j.cellsig.2007.10.002. Epub 2007 Oct 11. Cell Signal. 2008. PMID: 17993263 Review.
-
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins.Cancer Sci. 2008 Jul;99(7):1319-25. doi: 10.1111/j.1349-7006.2008.00840.x. Epub 2008 Apr 29. Cancer Sci. 2008. PMID: 18452557 Free PMC article. Review.
Cited by
-
Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1643-8. doi: 10.1073/pnas.1120985109. Epub 2012 Jan 17. Proc Natl Acad Sci U S A. 2012. PMID: 22307624 Free PMC article.
-
Excitatory neuron-specific SHP2-ERK signaling network regulates synaptic plasticity and memory.Sci Signal. 2019 Mar 5;12(571):eaau5755. doi: 10.1126/scisignal.aau5755. Sci Signal. 2019. PMID: 30837304 Free PMC article.
-
IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.Oncotarget. 2014 May 15;5(9):2562-74. doi: 10.18632/oncotarget.1812. Oncotarget. 2014. PMID: 24810113 Free PMC article.
-
An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies.Cardiovasc Drugs Ther. 2023 Dec;37(6):1193-1204. doi: 10.1007/s10557-022-07324-0. Epub 2022 Feb 14. Cardiovasc Drugs Ther. 2023. PMID: 35156148 Free PMC article. Review.
-
Targeting protein tyrosine phosphatases for anticancer drug discovery.Curr Pharm Des. 2010 Jun;16(16):1843-62. doi: 10.2174/138161210791209027. Curr Pharm Des. 2010. PMID: 20337577 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous